Halthcare Analysts discuss the patiet community perspective on Friedreich’s Ataxia (relevant companies LRMR BIB PTCT LXEO DSGN) on an Analyst/Industry conference call to be held on October 3.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRMR:
- 3 Best Stocks to Buy Now, 9/30/2025, According to Top Analysts
- Larimar Therapeutics price target lowered to $7 from $10 at Baird
- Buy Rating for Larimar Therapeutics Driven by Promising Data and Unmet Need in Friedreich’s Ataxia
- EA acquired in go-private deal for $55B, Carnival reports Q3 beat: Morning Buzz
- Optimistic Buy Rating for Larimar Therapeutics Amid Promising Data and Safety Adjustments